352 related articles for article (PubMed ID: 32113888)
1. Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis.
Tamburrino D; Crippa S; Partelli S; Archibugi L; Arcidiacono PG; Falconi M; Capurso G
Dig Liver Dis; 2020 Apr; 52(4):392-399. PubMed ID: 32113888
[TBL] [Abstract][Full Text] [Related]
2. The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.
Jeon CY; Pandol SJ; Wu B; Cook-Wiens G; Gottlieb RA; Merz CN; Goodman MT
PLoS One; 2015; 10(4):e0121783. PubMed ID: 25830309
[TBL] [Abstract][Full Text] [Related]
3. Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer.
Huang BZ; Chang JI; Li E; Xiang AH; Wu BU
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040693
[TBL] [Abstract][Full Text] [Related]
4. Statin use is associated to a reduced risk of pancreatic cancer: A meta-analysis.
Archibugi L; Arcidiacono PG; Capurso G
Dig Liver Dis; 2019 Jan; 51(1):28-37. PubMed ID: 30314951
[TBL] [Abstract][Full Text] [Related]
5. Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials.
Xia DK; Hu ZG; Tian YF; Zeng FJ
Drug Des Devel Ther; 2019; 13():405-422. PubMed ID: 30774306
[TBL] [Abstract][Full Text] [Related]
6. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
Choi JH; Lee SH; Huh G; Chun JW; You MS; Paik WH; Ryu JK; Kim YT
Cancer Med; 2019 Dec; 8(17):7419-7430. PubMed ID: 31637875
[TBL] [Abstract][Full Text] [Related]
7. Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study.
Joliat GR; Gaspar-Figueiredo S; Labgaa I; Vrochides D; Perinel J; Adham M; Demartines N; Schäfer M
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17007-17014. PubMed ID: 37740766
[TBL] [Abstract][Full Text] [Related]
8. Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.
E JY; Lu SE; Lin Y; Graber JM; Rotter D; Zhang L; Petersen GM; Demissie K; Lu-Yao G; Tan XL
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1225-1232. PubMed ID: 28619830
[No Abstract] [Full Text] [Related]
9. Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.
Jian-Yu E ; Graber JM; Lu SE; Lin Y; Lu-Yao G; Tan XL
Curr Med Chem; 2018; 25(22):2595-2607. PubMed ID: 28403788
[TBL] [Abstract][Full Text] [Related]
10. Statin Use and Risk of Pancreatic Cancer: An Updated Meta-analysis of 26 Studies.
Zhang Y; Liang M; Sun C; Qu G; Shi T; Min M; Wu Y; Sun Y
Pancreas; 2019 Feb; 48(2):142-150. PubMed ID: 30640225
[TBL] [Abstract][Full Text] [Related]
11. Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer.
Kozak MM; Anderson EM; von Eyben R; Pai JS; Poultsides GA; Visser BC; Norton JA; Koong AC; Chang DT
Pancreas; 2016 Jan; 45(1):64-70. PubMed ID: 26474429
[TBL] [Abstract][Full Text] [Related]
12. Statin treatment and outcomes of metastatic pancreatic cancer: a pooled analysis of two phase III studies.
Abdel-Rahman O
Clin Transl Oncol; 2019 Jun; 21(6):810-816. PubMed ID: 30465184
[TBL] [Abstract][Full Text] [Related]
13. Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer.
Hamada T; Khalaf N; Yuan C; Morales-Oyarvide V; Babic A; Nowak JA; Qian ZR; Ng K; Rubinson DA; Kraft P; Giovannucci EL; Stampfer MJ; Fuchs CS; Ogino S; Wolpin BM
Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1300-1306.e3. PubMed ID: 29474971
[TBL] [Abstract][Full Text] [Related]
14. The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis.
Schorn S; Demir IE; Haller B; Scheufele F; Reyes CM; Tieftrunk E; Sargut M; Goess R; Friess H; Ceyhan GO
Surg Oncol; 2017 Mar; 26(1):105-115. PubMed ID: 28317579
[TBL] [Abstract][Full Text] [Related]
15. Statin use and risk of pancreatic cancer: a meta-analysis.
Cui X; Xie Y; Chen M; Li J; Liao X; Shen J; Shi M; Li W; Zheng H; Jiang B
Cancer Causes Control; 2012 Jul; 23(7):1099-111. PubMed ID: 22562222
[TBL] [Abstract][Full Text] [Related]
16. The impact of neoadjuvant therapy on the histopathological features of pancreatic ductal adenocarcinoma - A systematic review and meta-analysis.
Schorn S; Demir IE; Reyes CM; Saricaoglu C; Samm N; Schirren R; Tieftrunk E; Hartmann D; Friess H; Ceyhan GO
Cancer Treat Rev; 2017 Apr; 55():96-106. PubMed ID: 28342938
[TBL] [Abstract][Full Text] [Related]
17. Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials.
Farooqi MAM; Malhotra N; Mukherjee SD; Sanger S; Dhesy-Thind SK; Ellis P; Leong DP
PLoS One; 2018; 13(12):e0209486. PubMed ID: 30571754
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Celiac Neurolysis and Splanchnicectomy on Survival in Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Ye L; Schorn S; Pergolini I; Safak O; Demir E; Istvanffy R; Friess H; Ceyhan GO; Demir IE
Dig Surg; 2022; 39(1):51-59. PubMed ID: 34903684
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.
Michelakos T; Pergolini I; Castillo CF; Honselmann KC; Cai L; Deshpande V; Wo JY; Ryan DP; Allen JN; Blaszkowsky LS; Clark JW; Murphy JE; Nipp RD; Parikh A; Qadan M; Warshaw AL; Hong TS; Lillemoe KD; Ferrone CR
Ann Surg; 2019 Apr; 269(4):733-740. PubMed ID: 29227344
[TBL] [Abstract][Full Text] [Related]
20. Effects of statin exposure and lung cancer survival: A meta-analysis of observational studies.
Chen Y; Li X; Zhang R; Xia Y; Shao Z; Mei Z
Pharmacol Res; 2019 Mar; 141():357-365. PubMed ID: 30641276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
